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As bstract. Marrow radioiron uptake and mar-
row blood flow were measured in order to evaluate iron
supply for erythropoiesis. Normal, phenylhydrazine-
treated and bled animals were studied. The plasma iron
turnover of seven normal rabbits was 1.49±0.22 mg/dl
whole blood per d, of 11 rabbits treated 4 d before with
phenylhydrazine was 5.16±1.81, and of four bled animals
the plasma iron turnover was 3.75±1.61. The cardiac
output and the percentage of blood flow to the marrow
was increased in phenylhydrazine-treated and bled ani-
mals. Marrow iron flow in phenylhydrazine-treated an-
imals was 38.3±32.6 gg/min per kg as compared with
control values of 7.0±1.3 (P < 0.01). This was due to an
increase in marrow flow, an increase in plasma iron, and
an increase in plasmatocrit. In bled animals, in spite of
an increased marrow blood flow, marrow iron flow of
7.3±2.2 was similar to that of control animals due to a
lower plasma iron concentration. The calculated marrow
iron extraction of 3.7±2.4% in phenylhydrazine-treated
animals was not different from that of control animals
of 4.3+ 1.1, whereas extraction was increased in bled an-
imals to 7.9±1.3 (P < 0.01). In additional studies oftrans-
fused animals, acutely induced anemia was associated
with an increased cardiac output, but also with a relative
decrease in marrow flow, which left marrow iron supply
unaffected. It would appear from these studies that an
important mechanism for meeting the increased iron re-
quirement of the hyperplastic erythroid marrow is an
increase in marrow blood flow.
Introduction
Internal iron delivery is determined by the relation between
available iron supply and tissue requirements. Supply is rep-
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resented by the amount of transferrin iron reaching the tissue
per unit time and by the degree of saturation of transferrin with
iron (1). Previous studies have emphasized the importance of
the amount of diferric transferrin present, since this complex
is capable of delivering much more iron than monoferric trans-
ferrin (2, 3). The total number of iron-containing transferrin
molecules vs. membrane receptor number is also important,
since iron uptake will be decreased if the number of iron-loaded
transferrin molecules is insufficient to saturate receptors. In ex-
amining these various relationships, it is essential to measure
blood flow, about which little is known.
Methods
New Zealand male rabbits weighing between 2.8 and 3.2 kg were main-
tained on a Purina rabbit chow diet (Ralston Purina Co., St. Louis,
MO). Some of these animals were studied in their basal state, and some
were studied 4 d after erythropoiesis had been stimulated by the intra-
venous injection ofacetylphenylhydrazine (30 mg/kg). Additional animals
were bled 10-20 ml/kg three to five times with replacement of plasma
during a 2-wk period before the study. Reticulocyte counts of normal
operated animals were 87±46 X 103hdl, of animals on the fourth day
after phenylhydrazine injections were 704±239, and of bled animals
were 585±123.
On the day of the experiment, animals were anesthetized by the
intramuscular injection of a 1:1 mixture of Vetalar (Parke Davis & Co.,
Morris Plains, NJ) and Rompun (Haver-Lockhart, Shawnee, kS) at a
dosage of 50 mg/kg and 10 mg/kg, respectively. Measurements were
made ofplasma iron turnover (PIT)' employing radioiron and of marrow
blood flow employing isotopically-labeled microspheres. At the end of
the experiment, animals were killed by exsanguination and the skin and
viscera were removed. The remaining carcass was autoclaved overnight
at a temperature of 1 30'C and a pressure of 1.4 kg/m2. After that, the
individual bones were removed and cleaned. The prolonged autoclaving
softened the bones to the extent that they could be packed at the bottom
of plastic tubes.
The femurs of some animals were processed before autoclaving so
as to separate marrow from bone. The femurs were first cleaned of
surrounding tissues and then cut longitudinally using a small rotary
saw. Samples of cortical bone and of marrow were weighed and radio-
activity was determined. From the relative weight of bone vs. marrow
and their relative activities, the distribution of radioiron and of labeled
microspheres were determined. Less than 1% of radioiron in the femur
was found in the bone (0.98±0.18% in five normal animals and
1. Abbreviations used in this paper: CO, cardiac output; PIT, plasma
iron turnover.
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0.85±0.22% in five animals with increased erythropoiesis). On the other
hand, some 15.2±2.8% of nticrospheres were localized in the bone of
normal animals and 13.4±1.5% in animals with increased erythropoiesis.
It appeared that iron was taken up exclusively by the marrow, but that
some 15% of blood flow was to bone rather than marrow.
Gamma-emitting isotopes (59Fe, 57Co, "3Sn) were differentially
counted in a Packard model 5330 counter (Packard Instrument Co.,
Downers Grove, IL). Plasma samples containing 59Fe and/or "Fe were
prepared by adding 0.25 ml plasma to 0.5 ml 0.1 N perchloric acid and
were then centrifuged. 10 ml ofaquasol (New England Nuclear, Boston,
MA) was added to 0.5 ml of the supernatant and the samples were
counted in a Tricarb scintillation spectrophotometer (Packard, model
2405, Packard Instrument Co.). Tissues and red cells containing 59Fe
and/or "Fe were wet ashed and prepared for liquid scintillation counting
by the methods of Eakins and Brown (4). Appropriate corrections were
made for cross counting and for geometry.
Plasma iron and total iron-binding capacity were determined by
standard methods (5, 6). Hematocrits were determined by the micro
technique and the red cell number by particle counting (Coulter electronic
counter, model B, Coultbr Electronics, Inc., Hialeah, FL). Reticulocyte
percentage was determined by examining 1,000 red cells, each on two
different slides, and was converted through the red cell count to retic-
ulocytes per microliter of blood.
Measurements of blood flow. Microspheres labeled with 17Co and
"3Sn with a size of 15.2±1.0 Am and 15.6±1.4 Am, respectively (New
England Nuclear), were used, since they had been shown not to shunt
through vascular anastomosis in rabbit bones (7). With the animal under
anesthesia, between four- and eight-million microspheres were injected
by needle directly into the left side of the heart.2 Beginning 30 s before
microsphere injection and continuing 2 min afterward, arterial blood
was withdrawn by pump from the central artery of the ear at a rate of
3.5 ml/min. This sample, along with the weighed standard injection,
was counted. Cardiac output (CO) was determined according to the
following formula: CO (ml/min) = blood removal rate (ml/min)
X (counts injected)/(counts removed). The percentage of the total flow
going to the marrow was obtained by counting total skeletal radioactivity
and by relating it to the total activity injected. Marrow blood flow (%)
= skeletal activity X 100 X F/counts injected. In this calculation, a
factor correction for the blood flow (F) of 0.85 in the normal and 0.87
in anemic animals was made for the portion of activity localized in the
bone. Blood flow in ml/min per kg was then determined according to
the formula: Marrow flow (ml/min per kg) = CO (ml/min per kg)
X marrow flow (%)/ 100. In order to evaluate uniformity ofmicrospheres
and radioiron distribution through the skeleton, determinations were
made in eight normal rabbits and in 10 animals with increased eryth-
ropoiesis. Distribution of radioiron between left and right side bones of
the body were virtually identical (r = 0.98). A similar correlation was
found with microspheres (r = 0.97).
Ferrokinetic measurements. Ferrokinetic measurements were carried
out in animals as previously described (8). 1 ml of a solution of ferrous
sulfate that contained 1-3 MCi radioiron in 1.0 Ag iron at pH 2 was
injected intravenously over a 5-min period in the marginal vein of the
ear. Thereafter, five or six samples of I ml each were drawn from the
central artery of the ear, with sampling time being adjusted to extend
beyond the anticipated T½/2 radioiron disappearance. Blood was either
placed on ice and spun within 1 h, or in animals with high numbers of
2. In the seven animals subjected to exchange transfusion, microspheres
were injected directly into the left atrium by a catheter, which had been
implanted 2-3 wk previously.
circulating reticulocytes it was rapidly centrifuged with separation of
red cells and plasma within 3 min of the time the sample was obtained.
Blood samples at 10 min and at the approximate T½/2 were analyzed
for plasma iron. When >90% of radioiron had disappeared from cir-
culating plasma, animals were killed by exsanguination in saline perfusion
over a 10-1 5-min period.
The effectiveness of perfusion in removing radioactivity due to labeled
red blood cells was studied in three animals compared with three others
in which perfusion was not carried out. The percentage of intravenously
injected 59Fe-labeled red blood cells remaining in the skeleton, liver,
and spleen in the nonperfused animals was 3.5±0.4, 9.6±2.2, and 0.3±0.1,
and in the perfused animals was 0.3±0.1, 1.6±1.8, and 0.09±0.01, re-
spectively. Accordingly, no correction was made for the 0.3% residual
red cell activity in calculating the amount of radioiron localized in the
skeleton.
Plasma iron turnover was calculated according to the formula pre-
viously described (9): PIT (mg/dl whole blood per day) = plasma iron
(Mg/%) X (100-Hct X 0.9)/T½/2 (min) X 100. The plasma iron used in
this formula was the extrapolated value at the T'/2 disappearance of
radioiron (8). Red cell activity was determined from the counts per
milliliter of washed red cells, the hematocrit, and the blood volume,
which was assumed to be 58 ml/kg (mean value obtained in 10 normal
animals). The iron supply to the erythroid marrow was calculated ac-
cording to the following formula: marrow iron flow (Mg/min per kg)
= plasma iron (Mg/dl) X marrow plasma flow (ml/min per kg). Plasma
iron uptake by the bone marrow was calculated from the PIT and from
the proportion of injected radioiron localized in the marrow at a time
when 90% of radioactivity had left the plasma. Marrow iron uptake
(mg/dl whole blood per day) = PIT (mg/dl whole blood per day)
X marrow radioactivity (%). The percentage of iron extracted from
plasma that circulated through the bone marrow was calculated from
the iron uptake by the marrow divided by the iron flow through the
marrow, according to the following formula: extraction (%) = marrow
iron uptake (Mg/min per kg) X 100/marrow iron flow (Mg/min per kg).
The rate of movement of erythrocytes into blood in animals with phen-
ylhydrazine anemia was determined from changes in circulating red cell
radioactivity after >90% of radioiron had disappeared from the plasma.
Over a 2-h period, red cell activity increased by <5%. On the basis of
this, it was not considered necessary in calculations of relative uptake
by marrow and by blood to make corrections for that radioactivity which
moved from marrow to blood during the study.
Statistical analysis. Nonparametric tests were employed: the Wil-
coxon for paired values, the Mann-Whitney for unpaired values, and
the Spearman rank correlation (10).
Results
Erythropoiesis in seven normal rabbits was characterized by
ferrokinetic measurements (Table I). These animals had a mean
plasma iron of 155±27 ,ug/dl and a plasma iron turnover of
1.49±0.22 mg/dl whole blood/d. These values were similar to
previous results (I 1), and there was the expected relationship
between transferrin saturation and PIT (r = 0.71, P < 0.01).
Mean erythron iron uptake in normal animals was 0.92 mg/dl
whole blood/d of which 77% was in the marrow and 23% in
the circulating blood. Mean cardiac output was 107 ml/min
per kg, ofwhich 6.4% went to the erythroid marrow. Only 4.3%
of transferrin iron passing through the marrow cavity was ex-
tracted by the marrow.
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12.2±5.8 and 14.4±6.4 ,ug/kg per min. Marrow iron extraction
was not significantly affected (4.6±1.8 vs. 4.0±3.3).
Discussion
Hematocrit (%)
Plasma iron (/ug/dl)
Transferrin saturation (%)
T½/2 (min)
Total PIT (mg/dl whole
blood/d)
Marrow uptake
(mg/dl whole blood/d)
Blood uptake
(mg/dl whole blood/d)
Cardiac output
(ml/min/kg)
Marrow flow (% of CO)
Marrow Fe flow
(Agl/minlkg)
Marrow Fe extraction
(% ofmarrow iron flow)
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In certain anemias associated with erythroid hyperplasia, there
38±2 22±5* 21±3* is evidence that a relative iron deficiency exists. The expected
155±27 212±105* 68±27* macrocytosis characteristic of the stimulated erythron may not
57±12 63±28 18±8
70±14 33±15* 15±2* be seen despite a normal plasma iron concentration, which
suggests a limitation in hemoglobin production by the expanded
1.49±0.22 5.61±1.81* 3.73±1.61* population of erythroid precursors ( 12). Likewise, red cell pro-
toporphyrin, an indicator ofred cell iron deficiency, may increase
0.71±0.10 2.19±0.71* 1.45±0.63* when the production rises to over five times normal, despite a
0.21±0.03 1.74±0.56* 1.16±0.50* normal plasma iron or transferrin saturation (13), which indicates
a relative deficiency in iron supply. The present studies were
107±12 174±71* 153±50 undertaken to examine iron flow to the marrow under normal
6.4±0.8 12.3±5.3* 8.6±1.1 conditions and with erythroid hyperplasia at different levels of
7.0±1.3 38.3±32.6* 7.3±2.2 plasma iron.
Rabbits were selected, since their iron kinetics had been
4.3±1.1 3.7±2.4 7.9+1.3* studied in detail (11) and since the behavior of the transferrin
_____ receptor system closely resembled that of man (Huebers, H.,
ues of normal animals using the Mann-Whit- and C. A. Finch, unpublished observations). By measuring the
PIT and localization of radioiron in body tissues, it was possible
to quantitate iron uptake, and more especially, the uptake of
the erythroid marrow and of circulating reticulocytes. For mea-
arried out in 11 animals with anemia surement ofCO, a microsphere technique was employed whereby
Lzine. Mean PIT was increased to 5.61 the labeled spheres were injected by needle directly into the left
% of the erythron uptake of 3.39 mg/ side of the heart (14). The microsphere distribution was sym-
he circulating blood. CO was increased metrical on the two sides of the skeleton, which indicated a
of blood flowing through the marrow uniform distribution. Within the skeleton itself, some 85% of
ncreased flow along with the elevated the microspheres were found in the marrow as compared with
more than fivefold increase in marrow bone. These results in rabbits were similar to those reported in
traction of radioiron from blood cir- dogs by Gross et al. (7).
rrow was 3.7%. The cardiac output of 120±35 ml/min per kg in normal
ith the same degree of anemia had a anesthetized animals was somewhat below that reported by Syf-
blood/d, which was intermediate be- testad and Boelkins (15) of 165±24 ml/min per kg in unanes-
ylhydrazine-treated animals. CO was thetized operated animals. The marrow flow of 10.7% of CO
oportion ofblood going to the marrow was similar to that described in other reports (7, 15). The iron
Yo. Marrow iron flow was not different marrow blood flow greatly exceeded marrow requirements for
rcentage extraction increased approx- iron and a plasma iron extraction of 4.3% was calculated.
ianimals with increased erythropoiesis, The production of hemolytic anemia by phenylhydrazine
irrow was well correlated with PIT (r is associated with an initial destruction of '-20% ofthe circulating
ie marrow flow showed a correlation red cell mass each day (12). Proliferation ofthe erythroid marrow
P < 0.01). No correlation was found follows with a reticulocytosis in circulation and a rapid recovery
emia and bone marrow blood or iron of the hematocrit over a period of 7-10 d. The plasma iron is
elevated and the transferrin is nearly saturated over the first 2-
lf might produce changes in marrow 3 d and thereafter returns gradually to normal or subnormal
ction, an additional study was carried levels. Our study was made on the fourth day, when anemia
(change transfusion lowered their he- was severe and red cell proliferation marked, with a mean cir-
carried out before and immediately culating reticulocyte count of eight times basal. A conspicuous
)n was not significantly affected, i.e., finding was that the proportion of erythron radioiron taken up
ood/d before and 2.1±0.9 afterward. by circulating reticulocytes had doubled, i.e., an increase from
,, but bone marrow flow was decreased 22% in normal animals to 44%. Thus, an increased proportion
w iron flow essentially unchanged, i.e., ofradioiron uptake is independent ofmarrow flow. Actual mar-
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Table I. Values ofthe Different Parameters ofthe
Normal, Phenylhydrazine-treated, and Bled Animals
Phenylhydrazine-bled
animals treated
Normal
(n= 7)
row iron uptake was increased only three times. Nevertheless,
marrow iron flow had increased more than fivefold, due to the
increase in plasma iron concentration, in plasmatocrit, and in
marrow blood flow. Thus, available iron increased in these an-
imals more than did marrow requirements. The opposite sit-
uation occurred in four bled animals where iron supply was
reduced while marrow requirements were increased.
Comparing phenylhydrazine-treated and bled animals there
is a considerably greater increase in PIT, in marrow iron uptake,
and in reticulocyte output of the animals undergoing increased
red cell breakdown. While there has been some question as to
whether hemolysis in some special way augments erythropoiesis
(16), it seems reasonable to explain the difference by the limited
supply of iron. Not only is hemoglobin synthesis within the
individual cell reduced when iron supply decreases, but there
is also ample evidence that stem cell maturation is markedly
curtailed in iron deficient anemia as compared with hemolytic
anemia (17). That such an effect was demonstrated in bled
animals when iron extraction was only 8% suggests that the
capacity of the marrow to remove iron is limited.
The increased blood flow to the marrow was helpful in
balancing the increased marrow requirements. Previous studies
with an isolated femur from phenylhydrazine-treated animals
have also indicated an increased flow in this in vitro experimental
setting (18). Thus, marrow flow would seem to behave similarly
to the flow in other tissues and be regulated by metabolic activity.
Obviously, other factors can influence blood flow, and it
was of concern that anemia per se might have an influence on
marrow flow as well as on erythropoiesis. CO has been observed
by Richardson and Guyton (19) to increase in dogs whose he-
matocrits were rapidly lowered by blood exchange without vol-
ume exchange. However, our animals made acutely anemic by
exchange transfusion with plasma showed no change in marrow
iron supply, despite some immediate change in cardiac output.
Thus, it was the increased erythropoiesis rather than the anemia
that was responsible for increased marrow flow.
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